Company / Cost of Revenue
TransMedics Group, Inc. Cost of Revenue History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$242.7M
FY2025
5-year range
$9.1M / $242.7M
FY2021-FY2025
Trend
+35.2%
vs FY2024
Sector context
#72 of 107
Health Care
What the data says
At $243M, TransMedics Group, Inc.'s cost of revenue ranks #36 of 107 in the Health Care sector. Cost of Revenue has increased for 5 consecutive years, from $9M in FY2020 to $243M in FY2025.
Based on SEC 10-K filings.
$243M in FY2025 with a 5-year CAGR of +93.3%.
Increased from $88M to $243M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +105.0%
- 5-Year CAGR
- +93.3%
- 10-Year CAGR
- -
Sector benchmark
#36 of 107 in Health CareTop 33% of 107This company $242.7M Sector average $11.8B
▼
-97.9% below sector average
Key checks
Key Insights
- TransMedics Group, Inc.'s cost of revenue has grown for 5 consecutive years.
- 5-year CAGR of +93.3%, indicating consistent growth.
- In FY2025, cost of revenue increased 35.2% year-over-year.
- Ranks #72 out of 107 companies in the Health Care sector.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $242.7M | +35.2% |
| FY2024 | $179.5M | +105.0% |
| FY2023 | $87.5M | +210.5% |
| FY2022 | $28.2M | +209.6% |
| FY2021 | $9.1M | +1.1% |
| FY2020 | $9.0M | -7.6% |
| FY2019 | $9.7M | +33.7% |
| FY2018 | $7.3M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026